Canadas Drug Agency Recommends Funding Lecanemab for Early-Stage...

Beitreten

Anmelden

Registrieren

Suche

Theme Switcher

Nachtmodus

einen Link geteilt

2026-07-16 17:00:08

Canadas Drug Agency Recommends Funding Lecanemab for Early-Stage Alzheimers Disease

Lecanemab is shown in this handout photo. Lecanemab is an antibody that targets the buildup of amyloid plaque in the brain, which is believed to be an underlying cause of Alzheimer's disease. The Canadian

0 Kommentare 0 Geteilt 20 Ansichten